Biochimie, 2023, 206:150-153

Characterization of a novel natural tetracenomycin reveals crucial role of 4-hydroxy group in ribosome binding

The aromatic polyketides tetracenomycins were recently found to be potent inhibitors of protein synthesis. Their binding site is located in a unique locus within the tunnel of the large ribosomal subunit. Here we report the isolation and structure elucidation of a novel natural tetracenomycin congener - O-Me-tetracenomycin C (O-Me-TcmC). This compound is isomeric to tetracenomycin X (TcmX), however, in contrast to TcmX, O-Me-TcmC exhibited no antimicrobial activity and was unable to inhibit protein synthesis in vitro. Structural alignment of tetracenomycins to the binding locus from cryo-EM TcmX-70S ribosome data revealed the crucial role of the 4-hydroxyl group. These findings are important for further development of semi-synthetic tetracenomycins as potential antibacterials.

Alferova VA, Maviza TP, Biryukov MV, Zakalyukina YV, Polshakov VI, Sergiev PV, Korshun VA, Osterman IA

IBCH: 10330
Ссылка на статью в журнале: https://linkinghub.elsevier.com/retrieve/pii/S0300908422002826
Нет данных о цитировании
Данные статьи проверены модераторами 2022-12-01

Список научных проектов, где отмечена публикация

  1. Development of means of prevention and treatment of COVID-19 and concomitant infectious diseases using genetic technologies (September 28, 2021 — December 31, 2023). Gabibov A.G., Andreev D.E., Aralov A.V., Bezuglov V.V., Belogurov A.A., Vodovozova E.L., Zvyagin A.V., Konstantinova I.D., Korshun V.A., Ovchinnikova T.V., Rubcov Y.P., Smirnov I.V., Tonevickiy A.G.. Agreement / contract, Ministry of Science.